MLP SAĞLIK HİZMETLERİ A.Ş.

Transaction in Own Shares • Jun 7, 2022

Summary Info	Notification Regarding Share Buy-Back Transactions Dated June 7, 2022
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Company Performs the Buy-Back	MLP SAĞLIK HİZMETLERİ A.Ş.
Company Subject to Buy-Back	MLP SAĞLIK HİZMETLERİ A.Ş.

Type Of Buy-Back	Other
The Purpose of Buy-Back	To support healthy price formation and to offer shareholders an attractive long-term investment opportunity
Board Decision Date	25.05.2022
Number Of Shares To Be Acquired	20.803.720
Maximum Amount To Be Paid (TL)	650.000.000

Details of Buy-Back

Code of Share Subject to Buy-back	Transaction Date	Nominal Value of Shares Subject to Transaction (TRY)	Ratio To Capital (%)	Transaction Price (TRY / Unit)	Privileges, If Any, Associated With These Shares
B Grubu, MPARK, TREMLPC00021	27.05.2022	150.000	0,072	34,56	-
B Grubu, MPARK, TREMLPC00021	30.05.2022	90.000	0,043	36,42	-
B Grubu, MPARK, TREMLPC00021	31.05.2022	50.000	0,024	36,07	-
B Grubu, MPARK, TREMLPC00021	01.06.2022	45.000	0,022	36,03	-
B Grubu, MPARK, TREMLPC00021	02.06.2022	50.000	0,024	36	-
B Grubu, MPARK, TREMLPC00021	03.06.2022	41.000	0,02	36,69	-
B Grubu, MPARK, TREMLPC00021	06.06.2022	44.000	0,021	36,4	-
B Grubu, MPARK, TREMLPC00021	07.06.2022	40.000	0,019	35,64	-

Additional Explanations

Pursuant to share buyback transactions initiated with the resolution of the Board of Directors of MLP Sağlık Hizmetleri A.Ş. dated May 25, 2022,

On June 7, 2022, MPARK shares with TL 40,000 nominal value were repurchased within a price range of TL 35.40 – TL 36.10 (weighted average TL 35.64) per share on Istanbul Stock Exchange by MLP Sağlık Hizmetleri A.Ş.,

As of June 7, 2022, total nominal value of repurchased shares have become TL 510,000 which represents 0.2451% of the share capital, following the transactions.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.